Insulet Corp. (PODD)
131.69
+0.90
(+0.69%)
USD |
NASDAQ |
Oct 02, 16:00
131.64
-0.05
(-0.04%)
After-Hours: 20:00
Insulet Gross Profit Margin (Quarterly) : 72.56% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 72.56% |
| March 31, 2026 | 70.63% |
| December 31, 2025 | 72.76% |
| September 30, 2025 | 72.70% |
| June 30, 2025 | 70.31% |
| March 31, 2025 | 72.79% |
| December 31, 2024 | 72.72% |
| September 30, 2024 | 70.12% |
| June 30, 2024 | 68.41% |
| March 31, 2024 | 70.16% |
| December 31, 2023 | 71.28% |
| September 30, 2023 | 68.36% |
| June 30, 2023 | 66.13% |
| March 31, 2023 | 66.49% |
| December 31, 2022 | 58.29% |
| September 30, 2022 | 54.69% |
| June 30, 2022 | 62.99% |
| March 31, 2022 | 70.38% |
| December 31, 2021 | 68.74% |
| September 30, 2021 | 67.89% |
| June 30, 2021 | 68.73% |
| March 31, 2021 | 65.72% |
| December 31, 2020 | 60.26% |
| September 30, 2020 | 65.90% |
| June 30, 2020 | 62.66% |
| Date | Value |
|---|---|
| March 31, 2020 | 63.69% |
| December 31, 2019 | 63.66% |
| September 30, 2019 | 63.70% |
| June 30, 2019 | 65.38% |
| March 31, 2019 | 66.49% |
| December 31, 2018 | 66.59% |
| September 30, 2018 | 67.16% |
| June 30, 2018 | 65.73% |
| March 31, 2018 | 61.03% |
| December 31, 2017 | 62.91% |
| September 30, 2017 | 61.43% |
| June 30, 2017 | 59.65% |
| March 31, 2017 | 59.54% |
| December 31, 2016 | 58.74% |
| September 30, 2016 | 59.75% |
| June 30, 2016 | 58.94% |
| March 31, 2016 | 54.24% |
| December 31, 2015 | 45.27% |
| September 30, 2015 | 46.43% |
| June 30, 2015 | 45.48% |
| March 31, 2015 | 53.59% |
| December 31, 2014 | 50.54% |
| September 30, 2014 | 50.73% |
| June 30, 2014 | 49.66% |
| March 31, 2014 | 47.44% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| DexCom, Inc. | 63.44% |
| Abbott Laboratories | 52.64% |
| Boston Scientific Corp. | 66.50% |
| PROCEPT BioRobotics Corp. | 66.01% |
| Globus Medical, Inc. | 65.92% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 26.48% |
| Return on Assets | 11.85% |
| Return on Invested Capital | 15.09% |
| Profit Margin (Quarterly) | 11.85% |
| Operating Margin (Quarterly) | 16.15% |
| Return on Net Operating Assets | 19.27% |